That raises a question: if practical-tier inference commoditizes, how does any company justify the ever-larger capex to push the frontier?
OpenAI's pitch is that their business model should "scale with the value intelligence delivers." Concretely, that means moving beyond API fees into licensing and outcome-based pricing in high-value R&D sectors like drug discovery and materials science, where a single breakthrough dwarfs compute cost. That's one possible answer, though it's unclear whether the mechanism will work in practice.
AGI. [waves hands at the infinite money machine]
I think you're overestimating, or oversimplifying. Maybe both.
> I think you're overestimating, or oversimplifying
Yeah if you only read comments on HN but not the actual linked article you will get oversimplified conclusion. Like, duh?
Curiously, for most submissions it's the opposite - comments are much more useful and nuanced than the source being discussed.
Assuming you used o3, that would cost $58800 per week. That’s an expensive bet for only 50% odds in your favor.
Of course the agents are only that good on benchmarks, in reality your odds are worse. Maybe roulette instead?